Pancreatic B-cell proliferation in persistent hyperinsulinemic hypoglycemia of infancy: an immunohistochemical study of 18 cases.

Details

Serval ID
serval:BIB_AC699E1BD963
Type
Article: article from journal or magazin.
Collection
Publications
Title
Pancreatic B-cell proliferation in persistent hyperinsulinemic hypoglycemia of infancy: an immunohistochemical study of 18 cases.
Journal
Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc
Author(s)
Sempoux C., Guiot Y., Dubois D., Nollevaux M.C., Saudubray J.M., Nihoul-Fekete C., Rahier J.
ISSN
0893-3952 (Print)
ISSN-L
0893-3952
Publication state
Published
Issued date
1998
Peer-reviewed
Oui
Volume
11
Number
5
Pages
444-449
Language
english
Notes
Publication types: Journal Article ; Research Support, Non-U.S. Gov'tPublication Status: ppublish
Abstract
Persistent hyperinsulinemic hypoglycemia of infancy (PHHI) is characterized by severe hypoglycemia related to inappropriate insulin secretion. Morphologically, a tumoral and a nontumoral form are recognized. The tumoral form can be subdivided into adenomatous hyperplasia (in infants) and adenoma (in children). On the other hand, nesidioblastosis, considered until recently as a persistent B-cell replication, has repeatedly been proposed as the condition responsible for the nontumoral form of PHHI. We studied the proliferation rate of B cells in 18 patients affected by PHHI (7 nontumoral and 11 tumoral cases, including 4 adenomas and 7 adenomatous hyperplasias) and in 18 age-matched controls, using a double immunohistochemical technique detecting Ki-67, a nuclear endogenous antigen only present during cell proliferation, and insulin as pancreatic B-cell markers. Our results clearly show that "nesidioblastosis" is not related to an abnormal B-cell proliferation, because the B-cell labeling index (LI), reported as the mean plus or minus the standard error of the mean, is not statistically different between nontumoral PHHI (29.4 +/- 7.4) and age-matched controls (19.6 +/- 5.3). Furthermore, the Ki-67 positivity was not more prominent in small clusters of B cells in nesidioblastosis than in large islets. In tumoral PHHI, the LI was significantly higher in cases of focal adenomatous hyperplasia (77.6 +/- 10.9) than in either age-matched controls (19.9 +/- 6.9; P < .005) or in adenomas (27.9 +/- 13.7; P < .025); the values of this last group did not differ from those of age-matched controls (18.5 +/- 8.5). These data definitely demonstrate that nesidioblastosis does not correspond to an abnormal B-cell proliferation and that the focal forms of PHHI must be subclassified.
Keywords
Adenoma/metabolism, Adenoma/pathology, Adolescent, Cell Division/physiology, Child, Child, Preschool, Humans, Hyperinsulinism/metabolism, Hyperinsulinism/pathology, Hyperplasia/metabolism, Hyperplasia/pathology, Hypoglycemia/metabolism, Hypoglycemia/pathology, Immunohistochemistry, Infant, Insulin/metabolism, Islets of Langerhans/metabolism, Islets of Langerhans/pathology, Ki-67 Antigen/metabolism, Pancreatectomy/methods, Syndrome
Pubmed
Web of science
Create date
20/10/2016 16:38
Last modification date
20/08/2019 15:16
Usage data